Replies to post #597997 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

The only difference is IMMU had already received US FDA accelerated approval and was on verge of filing for full approval.

My valuation estimate is for when NWBO has received MHRA approval and filed with the FDA, so not much difference, therefore my assumption and comparison are almost identical. Now a comparison can of course not be made for DCVAXL has not been approved yet.
In my comparison I did not state that NWBO will be bought before any approval, it will not.

if a hypothetical bid does happen on UK alone, the BO would definitely be single digits IMO.

There will be no bid on the UK alone. If the UK is approved and NWBO has filed with the FDA then the buying party will understand that FDA approval is near. However, the most likely scenario is AFTER FDA approval NWBO will be bought for around the same amount as Immunomedics was bought for.